Literature DB >> 17382291

Mutational analysis of the N-glycosylation sites of Duffy antigen/receptor for chemokines.

Marcin Czerwinski1, Joanna Kern, Magdalena Grodecka, Maria Paprocka, Anna Krop-Watorek, Kazimiera Wasniowska.   

Abstract

The Duffy antigen/receptor for chemokines (DARC) is a seven-transmembrane glycoprotein carrying the Duffy (Fy) blood group antigen. The polypeptide chain of DARC contains two NSS motifs at positions 16 and 27 and one NDS motif at position 33 that represent canonical sequences for efficient N-glycosylation. To verify whether all of these three sites are occupied by a sugar chain, we generated mutants in which potential N-glycosylation sites (AsnXSer) were removed by replacement of serine by alanine. Seven DARC glycosylation variants, missing one (S18A, S29A, S35A), two (S18A.S29A, S18A.S35A, S29A.S35A), or three (S18A.S29A.S35A) glycosylation sites, were obtained. cDNA encoding DARC mutants was cloned into the eukaryotic expression vector pcDNA3.1/myc-HisA and expressed in human K562 cells. Stable transfectants expressing wild-type or mutated forms of Duffy were then lysed, purified by metal-affinity chromatography, and subjected to Western blots with an anti-Duffy monoclonal antibody. The gel electrophoresis data indicate that all three canonical sites are used for sugar attachment.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17382291     DOI: 10.1016/j.bbrc.2007.03.054

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  8 in total

1.  A recombinant dromedary antibody fragment (VHH or nanobody) directed against human Duffy antigen receptor for chemokines.

Authors:  Dorota Smolarek; Claude Hattab; Gholamreza Hassanzadeh-Ghassabeh; Sylvie Cochet; Carlos Gutiérrez; Alexandre G de Brevern; Rachanee Udomsangpetch; Julien Picot; Magdalena Grodecka; Kazimiera Wasniowska; Serge Muyldermans; Yves Colin; Caroline Le Van Kim; Marcin Czerwinski; Olivier Bertrand
Journal:  Cell Mol Life Sci       Date:  2010-05-11       Impact factor: 9.261

Review 2.  In silico studies on DARC.

Authors:  Alexandre G de Brevern; Ludovic Autin; Yves Colin; Olivier Bertrand; Catherine Etchebest
Journal:  Infect Disord Drug Targets       Date:  2009-06

3.  One-step immunopurification and lectinochemical characterization of the Duffy atypical chemokine receptor from human erythrocytes.

Authors:  Magdalena Grodecka; Olivier Bertrand; Ewa Karolak; Marek Lisowski; Kazimiera Waśniowska
Journal:  Glycoconj J       Date:  2012-01-14       Impact factor: 2.916

4.  The dimeric form of CXCL12 binds to atypical chemokine receptor 1.

Authors:  Julia C Gutjahr; Kyler S Crawford; Davin R Jensen; Prachi Naik; Francis C Peterson; Guerric P B Samson; Daniel F Legler; Johan Duchene; Christopher T Veldkamp; Antal Rot; Brian F Volkman
Journal:  Sci Signal       Date:  2021-08-17       Impact factor: 9.517

5.  A single point mutation in the gene encoding Gb3/CD77 synthase causes a rare inherited polyagglutination syndrome.

Authors:  Anna Suchanowska; Radoslaw Kaczmarek; Maria Duk; Jolanta Lukasiewicz; Dorota Smolarek; Edyta Majorczyk; Ewa Jaskiewicz; Anna Laskowska; Kazimiera Wasniowska; Magdalena Grodecka; Elwira Lisowska; Marcin Czerwinski
Journal:  J Biol Chem       Date:  2012-09-10       Impact factor: 5.157

6.  Studies of a murine monoclonal antibody directed against DARC: reappraisal of its specificity.

Authors:  Dorota Smolarek; Claude Hattab; Anna Buczkowska; Radoslaw Kaczmarek; Anna Jarząb; Sylvie Cochet; Alexandre G de Brevern; Jolanta Lukasiewicz; Wojciech Jachymek; Tomasz Niedziela; Magdalena Grodecka; Kazimiera Wasniowska; Yves Colin Aronovicz; Olivier Bertrand; Marcin Czerwinski
Journal:  PLoS One       Date:  2015-02-23       Impact factor: 3.240

Review 7.  Mechanisms of Regulation of the Chemokine-Receptor Network.

Authors:  Martin J Stone; Jenni A Hayward; Cheng Huang; Zil E Huma; Julie Sanchez
Journal:  Int J Mol Sci       Date:  2017-02-07       Impact factor: 5.923

8.  Duffy antigen receptor for chemokines and its involvement in patterning and control of inflammatory chemokines.

Authors:  Igor Novitzky-Basso; Antal Rot
Journal:  Front Immunol       Date:  2012-08-17       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.